Nissan Chemical Corporation is developing new manufacturing systems of large quantities of cell spheroids for regenerative medicines and drug discoveries and are now seeking potential collaborators for development of new applications of this system.
Large industrial company's life science division is looking for startups in data, AI/ML, modeling in drug development, cybersecurity.
Startup Lightning Talks presented at the 2024 MIT Tokyo Life Science Symposium.
Evonik’s Polymer Processing and Testing Lab in Allentown, PA, formerly used exclusively for internal R&D, is now available to startups through a new pilot program. The lab offers services ranging from collaborative research to defined analytical testing. Companies developing advanced polymer compounds or applications, especially in high-performance materials like polyamide 12 and PEEK, are encouraged to apply.
This conference will explore new or improved therapeutic approaches for finding cures for diseases which traditionally have been difficult to treat. This includes technologies for optimizing treatments and monitoring efficacy based on insights into cell and tissue state, circuitry, behavior, function, and responsiveness in normal and disease states, biomarker detection, better methods to predict and track efficacy, and enhanced manufacturing capabilities.
Looking for 100% recyclable and/or compostable and plastic free fiber to-go cup.
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.